4//SEC Filing
Kiernan Jane E 4
Accession 0001209191-22-052526
CIK 0001630627other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 7:00 PM ET
Size
7.6 KB
Accession
0001209191-22-052526
Insider Transaction Report
Form 4
Kiernan Jane E
Director
Transactions
- Award
Common Stock
2022-10-01+2,832→ 2,832 total - Award
Stock Option (Right to Buy)
2022-10-01+19,439→ 19,439 totalExercise: $22.07Exp: 2032-10-01→ Common Stock (19,439 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting October 1, 2023 such that the RSUs will be fully vested on October 1, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F2]The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on November 1, 2022 such that the stock option will be fully vested and exercisable on October 1, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001379171
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 7:00 PM ET
- Size
- 7.6 KB